Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Papaverine vs Heparin for Arterial Catheter Patency in Pediatrics
NCT03894904Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Apr 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of papaverine in vasospasm (2 arms), sponsored by UTHealth Houston. Primary endpoint: Number of Participants With Optimal Arterial Waveform. Started Apr 2019; status: completed.
02
Drugs
papaverine
03
Conditions
vasospasm
Beyond the preview
Go deeper on NCT03894904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03894904.